Jan 11, 2024 / 06:30PM GMT
Colin Minicus JPMorgan-Analyst
Morning, everyone. I'm Colin Minicus. I'm an associate here at JPMorgan Healthcare Group. It's my pleasure to welcome Lexicon to the 42nd Annual JP Morgan Healthcare Conference.
As just a quick reminder, we plan to hold Q&A at the end of today's session.
Now without further ado, please welcome CEO, Lonnel Coats.
Lonnel Coats Lexicon Pharmaceuticals - Inc. - CEO & Director
Thank you, Colin, and thank all of you who have made time to be here live at the conference and for all of those who are on webcast. Today, I'll be making forward-looking statements. Some of those statements certainly may have risk. I encourage you all to look at our SEC filings where our risks are contained there.
As always, I make these presentations on behalf of all the extraordinary men and women at Lexicon that work tirelessly every day to translate our mission into helping patients live better lives.
With that being said, let me move to the first slide and say for those of you who do not know much about
Lexicon Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Feb 07, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers